Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Operating Leases (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Operating Leases for 4 consecutive years, with $815000.0 as the latest value for Q4 2025.

  • Quarterly Operating Leases changed 0.12% to $815000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $815000.0 through Dec 2025, changed 0.12% year-over-year, with the annual reading at $815000.0 for FY2025, 0.12% changed from the prior year.
  • Operating Leases for Q4 2025 was $815000.0 at LENZ Therapeutics, up from $461000.0 in the prior quarter.
  • The five-year high for Operating Leases was $50.6 million in Q2 2023, with the low at $156000.0 in Q1 2024.
  • Average Operating Leases over 4 years is $8.0 million, with a median of $1.4 million recorded in 2023.
  • The sharpest move saw Operating Leases skyrocketed 1888.0% in 2023, then plummeted 97.92% in 2024.
  • Over 4 years, Operating Leases stood at $1.7 million in 2022, then soared by 2741.62% to $49.7 million in 2023, then tumbled by 98.36% to $814000.0 in 2024, then increased by 0.12% to $815000.0 in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $815000.0, $461000.0, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.